New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewé, Désirée M F M van der Heijde · Clinical Investigation · 2013
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Clinical Investigation · OMICS Publishing Group · article · 2013
Abstract
Spondyloarthritis (SpA) is an umbrella term for a group of diseases sharing genetic, molecular, immunological, clinical and imaging features. The last few years have witnessed a remarkable progress in the understanding of SpA. Notable advances include the recognition of MRI as a sensitive and specific tool for detecting axial inflammation and the recent development and validation of the Assessment of Spondyloarthritis International Society classification criteria for predominantly axial and predominantly peripheral SpA.
This approach has the advantage of better describing the disease, allowing earlier identification and treatment of the non-radiographic forms and potentially leading to improved outcomes. TNF α-blockers, which dramatically improve the clinical symptoms and signs of patients with ankylosing spondylitis, are now being tested in patients with non-radiographic axial SpA, with the first studies providing evidence that patients with the non-radiographic form of the disease also benefit from this...
Open the resolved locator · 10.4155/cli.12.148
Metadata licence: OpenAlex metadata (CC0)